biote Corp. Class A (BTMD)

Biote Corp.'s stock price has declined significantly over the past six months. The Q3 2025 earnings report showed an EPS that surpassed forecasts, but revenue missed expectations, leading to a slight increase in the stock price. Revenue saw a year-over-year decline due to slower clinic additions and lower procedure volumes, though dietary supplement revenue grew. Biote maintained its 2025 guidance and is undergoing organizational restructuring.

Specific demand seasonality for Biote Corp.'s products and services is not extensively detailed. However, the timing of seasonal promotions influences the demand for its dietary supplements. The company's dietary supplement business has shown strong growth, particularly through its e-commerce channel.

Biote Corp. operates as a practice-building business in the hormone optimization sector, focusing on training practitioners in bioidentical hormone replacement therapy. The company offers the "Biote Method" platform, including education, training, practice management software, and marketing support. Biote also sells branded dietary supplements and sterile pellet insertion kits.

Biote Corp. is headquartered in Irving, Texas, and has a network of approximately 8,600 medical providers across the U.S. as of 2022, indicating a significant domestic presence.

Biote has strong brand recognition among practitioners and patients. Potential risks to its reputation include decreased demand, negative media attention, and litigation. Specific events that have negatively impacted Biote Corp.'s brand reputation in the past year are not explicitly detailed in the available information.

Biote Corp. has 199 institutional owners and shareholders, holding a total of 17,594,795 shares. Institutional ownership accounts for 21.68% of the stock, while insiders hold 24.00%. Major institutional shareholders include 325 Capital Llc, Bandera Partners LLC, BlackRock, Inc., Vanguard Group Inc, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, IWM - iShares Russell 2000 ETF, Acadian Asset Management Llc, Geode Capital Management, Llc, Dimensional Fund Advisors Lp, and State Street Corp.